 EMERYVILLE, Calif. , July 21, 2021 PRNewswire -- Dynavax Technologies Corporation NASDAQ: DVAX, a biopharmaceutical company focused on developing and commercializing novel vaccines, will report second quarter 2021 financial results on Wednesday, August 4, 2021, after the U.S. financial markets close. 